← Back to directory
Krassimir Koynov
Researcher Next ID · RN-016800
Researcher · Biochemistry, Genetics and Molecular Biology
, Bulgaria
Not currently recruitingFunding unknown
- Works count
- 46
- Citation count
- 6,721
- H-index
- 9
- i10-index
- 9
Research interests
Biochemistry, Genetics and Molecular Biology
Medicine
Fibroblast Growth Factor Research
Medical Imaging and Pathology Studies
Sarcoma Diagnosis and Treatment
Cancer Immunotherapy and Biomarkers
Lung Cancer Treatments and Mutations
Publications
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
The Lancet Oncology · 2020 · 10.1016/s1470-2045(20)30539-8
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
The Lancet · 2019 · 10.1016/s0140-6736(19)32222-6
Current projects
No projects listed.